Amylyx Pharmaceuticals, Inc. Quarterly Current Ratio in % from Q3 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Amylyx Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q3 2022 to Q3 2024.
  • Amylyx Pharmaceuticals, Inc. Current Ratio for the quarter ending September 30, 2024 was 486 %, a 38.1% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 486 -299 -38.1% Sep 30, 2024
Q2 2024 565 -138 -19.6% Jun 30, 2024
Q1 2024 613 -121 -16.5% Mar 31, 2024
Q4 2023 705 -67.6 -8.75% Dec 31, 2023
Q3 2023 785 +62 +8.57% Sep 30, 2023
Q2 2023 703 Jun 30, 2023
Q1 2023 734 Mar 31, 2023
Q4 2022 772 Dec 31, 2022
Q3 2022 723 Sep 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.